Effects of vanadium complexes with organic ligands on glucose metabolism: A comparison study in diabetic rats

British Journal of Pharmacology

Volumn 126, Issue 2, 1999, Pages 467-477

  Reul, Bénédicte A ^a   Amin, Sean S ^b   Buchet, Jean Pierre ^a   Ongemba, Lumbe N ^a   Crans, Debbie C ^b   Brichard, Sonia M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Antidiabetic agents; Gene expression; Gluconeogenic enzymes; Glycolytic enzymes; Organic ligands; Streptozotocin diabetic rats; Toxicity; Vanadium

Indexed keywords

GLUCOKINASE; GLUCOSE; LIGAND; MESSENGER RNA; PYRUVATE KINASE; VANADIUM DERIVATIVE; VANADYL DERIVATIVE; VANADYL SULFATE;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; DIARRHEA; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLYCOLYSIS; HYPERGLYCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DISINFECTANTS; GLUCOKINASE; GLUCOSE; HYDROXYBUTYRATES; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; INSULIN; ISLETS OF LANGERHANS; LIGANDS; LIVER; LIVER GLYCOGEN; MALE; MUSCLES; ORGANOMETALLIC COMPOUNDS; PENTANONES; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRONES; PYRUVATE KINASE; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; VANADATES; VANADIUM COMPOUNDS;

EID: 0032929963     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702311     Document Type: Article

References (30)

1. Becker, D.J., Ongemba, L.N. & Henquin, J.C. (1994). Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats. Eur. J. Pharmacol., 260, 169-175.
2. Bevan, A.P., Burgess, J.W., Yale, J.F., Drake, P.G., Lachance, D., Baquiran, G., Shaver, A. & Posner, B.I. (1995). In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency. Am. J. Physiol., 268, E60-E66.
3. Boden, G., Chen, X., Ruiz, J., Van Rossum, G.D.V. & Turco, S. (1996). Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism, 45, 1130-1135.
4. Brichard, S.M. & Henquin, J.C. (1995). The role of vanadium in the management of diabetes. Trends Pharmacol. Sci., 16, 265-270.
5. Brichard, S.M., Henquin, J.C. & Girard, J. (1993). Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia, 36, 292-298.
6. Brichard, S.M., Okitolonda, W. & Henquin, J.C. (1988). Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology, 123, 2048-2053.
7. Buchet, J.P., Knepper, E. & Lauwerys, R. (1982). Determination of vanadium in urine by electrothermal atomic absorption spectrometry. Anal. Chim. Acta., 136, 243.
8. Caravan, P., Gelmini, L., Glover, N., Herring, F.G., Li, H., Mcneill, J.H., Rettig, S.J., Setyawati, I.A., Shuter, E., Sun, Y., Tracey, A.S., Yuen, V.G. & Orvig, C. (1995). Reaction chemistry of BMOV, Bis(maltolato)oxovanadium(IV)- a potent insulin mimetic agent. J. Am. Chem. Soc., 117, 12759-12770.
9. Chan, Y.L., Gutell, R., Noller, H.F. & Wool, I.G. (1984). The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J. Biol. Chem., 259, 224-230.
10. Cohen, N., Halbertham, M., Shlimovich, P., Chang, C.J., Shamson, H. & Rossetti, L. (1995). Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J. Clin. Invest., 95, 2501-2509.
11. Crans, D.C., Keramidas, A.D., Hoover-Litty, H., Anderson, O.P., Miller, M.M., Lemoine, L.M., Pleasic-Williams, S., Vandenberg, M., Rossomando, A.J. & Sweet, L.J. (1997). Synthesis, structure, and biological activity of a new insulinomimetic peroxovanadium compound: Bisperoxovanadium imidazole monoanion. J. Am. Chem. Soc., 119, 5447-5448.
12. Elberg, G., He, Z., Li, J., Sekar, N. & Shechter, Y. (1997). Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes, 46, 1684-1690.
13. Goldfine, A.B., Simonson, D.C., Folli, F., Patti, M.E. & Kahn, C.R. (1995). Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinot. Metab., 80, 3311-3320.
14. Heyliger, C.E., Tahiliani, A.G. & Mcneill, J.H. (1985). Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science, 227, 1474-1477.
15. Iynedjian, P.B., Ucla, C. & Mach, B. (1987). Molecular cloning of glucokinase cDNA. Development and dietary regulation of glucokinase mRNA in rat liver. J. Biol. Chem., 262, 6032-6038.
16. Jensen, P.K., Christiansen, J.S., Steven, K. & Parving, H.H. (1981). Renal function in streptozotocin-diabetic rats. Diabetologia, 21, 409-414.
17. Li, J., Elberg, G., Crans, D.C. & Shechter, Y. (1996). Evidence for the distinct vanadyl( + 4)-dependent activating system for manifesting insulin-like effects. Biochemistry, 35, 8314-8318.
18. Llobet, J.M. & Domingo, J.L. (1984). Acute toxicity of vanadium compounds in rats and mice. Toxicology Letters, 23, 227-231.
19. Mcneill, J.H., Yuen, V.G., Dai, S. & Orvig, c. (1995). Increased potency of vanadium using organic ligands. Mol. Cell. Biochem., 153, 175-180.
20. Mongold, J.J., Cros, G.H., Vian, L., Tep, A., Ramanadham, S., Siou, G., Diaz, J., Mcneill, J.H. & Serrano, J.J. (1990). Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology. Pharmacol. Toxicol., 67, 192-198.
21. Ozcelikay, A.T., Becker, D.J., Ongemba, L.N., Pottier, A.M., Henquin, J.C. & Brichard, S.M. (1996). Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. Am. J. Physiol., 270, E344-E352.
22. Posner, B.I., Faure, R., Burgess, J.W., Bevan, A.P., Lachance, D., Zhang-Sun, G., Fantus, I.G., Ngg, J.B., Hall, D.A., Soo Lum, B. & Shaver, A. (1994). Peroxovanadium compounds: a new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem., 269, 4596-4604.
23. Reul, B.A., Becker, D.J., Ongemba, L.N., Bailey, C.J., Henquin, J.C. & Brichard, S.M. (1997). Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate. J. Endocrinol., 155, 55-64.
24. Sakurai, H., Fujii, K., Watanabe, H. & Tamura, H. (1995). Orally active and long-term acting insulin-mimetic vanadyl complex: bis(picolinato)oxovanadium(IV). Biochem. Biophys. Res. Com., 214, 1095-1101.
25. Simon, M.P., Besmond, C., Cottreau, D., Weber, A., Chaumet-Riffaud, P., Dreyfus, J.C., Sala Trepat, J., Marie, J. & Kahn, A. (1983). Molecular cloning for L-type pyruvate kinase and aldolase B. J. Biol. Chem., 258, 14576-14584.
26. Tsiani, E. & Fantus, I.G. (1997). Vanadium Compounds: Biological Actions and Potential as Pharmacological Agents. Trends Endocrinol. Metab., 8, 51-58.
27. Yoo-Warren, H., Monahan, J.E., Short, J., Short, H., Bruzel, A., Wynshaw-Boris, A., Meisner, H.M., Samols, D. & Hanson, R.W. (1983). Isolation and characterization of the gene coding for cytosolic phophoenolpyruvate carboxykinase (GTP) from the rat. Proc. Natl. Acad. Sci. U.S.A., 80, 3656-3660.
28. Yuen, V.G., Orvig, C. & Mcneill, J.H. (1993a). Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Can. J. Physiol. Pharmacol., 71, 263-269.
29. Yuen, V.G., Orvig, C., Thompson, K.H. & Mcneill, J.H. (1993b). Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium (IV). Can. J. Physiol. Pharmacol., 71, 270-276.
30. Yuen, V.G., Orvig, C. & Mcneill, J.H. (1995). Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can. J. Physiol. Pharmacol., 73, 55-64.